Norwegian HealthTech startup HoloCare scales its commercial footprint across Europe, following UKCA and CE certification. The mixed reality and AI-powered platform will initially launch in five hospitals to support pre-surgical planning.
HoloCare’s software creates interactive 3D holograms of an individual patient’s organ, allowing surgeons to precisely plan and personalise surgeries to the patient’s unique anatomy. This better spatial understanding could support surgeons to carry out operations more efficiently and accurately – helping improve wait times, improve patient surgery outcomes and improve clinician wellbeing.
The technology will initially be available to improve the quality of planning for complex liver surgery (liver resections).
Professor Bjørn Edwin, Section Manager and Professor at the Intervention Centre, Oslo University Hospital where he specialises in liver and pancreas surgeries, has been using HoloCare’s software as part of the clinical research study. Edwin said: “As a surgeon specialising in minimally invasive surgery, HoloCare’s software has transformed the way I approach operations. I’m able to zoom in on the intricacies of a patient’s anatomy, to plan exactly how I will approach a surgery in the most efficient (and least invasive) way. I’ve worked closely with HoloCare’s team to really test the technology to its limits and have seen really promising results so far.”
The company’s newly CE Marked (Class 2b) technology – which means the company has been assessed to meet high safety, health, and environmental protection requirements, and can now trade in the European Economic Area (EEA) – is launching at five European hospitals, including Oslo University Hospital, Norway and Leeds Teaching Hospitals NHS Trust, UK.
The company plans to launch in a further 10 European hospitals in 2024.